Finanzwire Finanzwire
Basculer en Français
10316 Companies
213847 Keywords
143509 Articles
113176 Press releases
Headlines Articles Press releases LenioBio Remove
  1. Home
  2. Companies
  3. LenioBio
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/26/2025 at 09:10, 5 months 3 days ago

    MAIbe and LenioBio Partner to Advance Antibody Discovery

    AI-driven Platform Monoclonal Antibodies Cell-free Expression Therapeutic Discovery Biotechnology Collaboration
  • PRESS RELEASE

    published on 11/26/2025 at 09:05, 5 months 3 days ago

    mAIbe and LenioBio announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation monoclonal antibodies

    mAIbe and LenioBio collaborate to accelerate discovery of next-generation monoclonal antibodies through AI-driven platform and cell-free expression technology
    AI-driven Platform Monoclonal Antibodies MAIbe LenioBio Cell-free Expression Technology
    Logo of LenioBio
Accesswire
  • Published on 04/29/2026 at 15:30, 18 minutes ago

    Infield Minerals Announces Financing

  • Published on 04/29/2026 at 15:15, 33 minutes ago

    Reeflex Solutions Inc. Announces Filing of Q2 2026 Financial Results

  • Published on 04/29/2026 at 15:10, 38 minutes ago

    Karbon-X Introduces Corporate Emissions Calculator as Pressure to Quantify Carbon Exposure Accelerates

  • Published on 04/29/2026 at 14:31, 1 hour 17 minutes ago

    Worksport (NASDAQ:WKSP) Secures Tri-State Distribution, Books Initial Orders, Projected to be 7-Figure + Annual Account

  • Published on 04/29/2026 at 14:30, 1 hour 18 minutes ago

    Jaguar Health Announces Statistically Significant Results from Effectiveness Trial of Crofelemer (FDA Approved Canalevia-CA1) for Treatment of Chemotherapy-Induced Diarrhea in Dogs

View all ACCESSWIRE
EQS Group
  • Published on 04/29/2026 at 15:30, 18 minutes ago

    NAV GUIDANCE FOR THE 18 MONTHS ENDED 31 DECEMBER 2025, STRATEGIC TRANSACTION, DELAY IN PUBLICATION OF AUDITED ACCOUNTS AND TEMPORARY SUSPENSION OF LISTING

  • Published on 04/29/2026 at 15:13, 35 minutes ago

    tick Trading Software AG: Annual General Meeting Approves Dividend Payout of EUR 0.85 per Share

  • Published on 04/29/2026 at 15:10, 38 minutes ago

    Mayr-Melnhof Karton AG: Board mandate of Roman Billiani extended

  • Published on 04/29/2026 at 15:05, 43 minutes ago

    Duck Creek Launches Agentic Product Configurator to Accelerate Insurance Policy Product Implementation By 50%

  • Published on 04/29/2026 at 15:05, 43 minutes ago

    CORRECTION - Liquidation Announcement

View all EQS
Les Echos
  • Published on 04/29/2026 at 10:15, 5 hours 33 minutes ago

    Neoen launches construction of two new solar farms in Ireland, nearly doubling its capacity in the country

  • Published on 04/29/2026 at 09:00, 6 hours 48 minutes ago

    Aéroports de Paris SA - Terms of availability or consultation of the information mentioned in Article R.225-83 of the French Commercial Code, relating to the combined general meeting (ordinary and extraordinary) of 21 May 2026

  • Published on 04/29/2026 at 07:30, 8 hours 18 minutes ago

    Signing of the SPA for the sale of Novacel

  • Published on 04/28/2026 at 18:00, 21 hours 48 minutes ago

    LDC has received approval from the Competition and Markets Authority (CMA) for the acquisition of shares in Green Label

  • Published on 04/28/2026 at 17:57, 21 hours 51 minutes ago

    Peugeot Invest enters into an agreement to sell its stake in Immobilière Dassault for €75 million

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy